What is Inhibrx Biosciences, Inc.'s change in AP?

Inhibrx Biosciences, Inc. (INBX) reported change in AP of $2.82M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s change in AP changed year-over-year?

Inhibrx Biosciences, Inc.'s change in AP increased by 898.3% year-over-year, from -$353K to $2.82M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Inhibrx Biosciences, Inc. INBX Change in AP

Change in AP at other companies

PfizerPFE

-$117.25M+54.2%

Rogers CorporationROG

$8.1M+92.9%

Merck & Co.MRK

$27.5M-39.6%

Gilead SciencesGILD

-$67M+36.2%

Nuvation BioNUVB

$12.96M+209%

ArriVent BioPharma, Inc.AVBP

$2.81M+382%

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+546%

Enterprise value$1.42B+1,233%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s change in AP?: Inhibrx Biosciences, Inc. (INBX) reported change in AP of $2.82M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s change in AP changed year-over-year?: Inhibrx Biosciences, Inc.'s change in AP increased by 898.3% year-over-year, from -$353K to $2.82M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.